*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. By communiqué dated March 23, 2021, the New Caledonian Competition Authority announced that it had authorized, by decision no. 2021-DCC-01 of March 22, 2021, the acquisition of exclusive control of Medical Equipement by Handipharma. This authorization was given after the fact, when the transaction had already been completed. The sale of the shares of Medical Equipement to
ALERTS: EUROPEAN AND INTERNATIONAL LAW - FRENCH OVERSEAS TERRITORIES - NEW CALEDONIA - AUTHORIZATION - NOTIFICATION - EXCLUSIVE CONTROL - GUN-JUMPING
New Caledonia: The New Caledonian Competition Authority conditionally clears a controllable transaction that had not been notified to it and plans to sue the company for failure to notify the transaction before its completion (Médical Equipement / Handipharma)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.